| April 26, 1947 |
1,000 |
100 |
100 |
Cash |
Initial subscribers to the Memorandum of Association |
100,000 |
1,000 |
| June 30, 1967 |
5,000 |
100 |
- |
Cash |
Equity shares allotted pursuant to a bonus issue |
600,000 |
6,000 |
| August 28,1979 |
Sub-division of the equity shares from face value of ₹ 100 each to face value of ₹ 10 each |
600,000 |
60,000 |
| October 4, 1979 |
600,000 |
10 |
- |
N.A. |
Equity shares allotted pursuant to a bonus issue |
6,600,000 |
660,000 |
| November, 1979 |
803,600 |
10 |
10 |
Cash |
Equity shares allotted pursuant to rights issue |
14,636,000 |
1,463,600 |
| June 3, 1991 |
1,650,000 |
10 |
- |
Other than cash |
Allotment to shareholders of erstwhile Gujarat Glass Limited pursuant to a scheme of arrangement under Sections 391-394 of the Companies Act, 1956 |
31,136,000 |
3,113,600 |
| September 30, 1991 |
3,113,600 |
10 |
- |
N.A. |
Equity shares allotted pursuant to a bonus issue to the then existing shareholders |
62,272,000 |
6,227,200 |
| October 20, 1992 |
1,879,836 |
10 |
50 |
Cash |
Equity shares allotted pursuant to conversion of partly convertible debentures |
81,070,360 |
8,107,036 |
| July 29, 1993 |
4,053,518 |
10 |
- |
N.A. |
Equity shares allotted pursuant to a bonus issue |
121,605,540 |
12,160,554 |
| February 14, 17 and 19, 1994 |
3,030,000 |
10 |
330 |
Cash |
Preferential allotment to 22 allotees |
151,905,540 |
15,190,554 |
| August 4, 1994 |
2,200,000 |
10 |
90 |
Cash |
Issued against warrants attached to non-convertible debentures |
173,905,540 |
17,390,554 |
| September 16, 1996 |
1,039,410 |
10 |
- |
Other than cash |
Allotment to shareholders of erstwhile Sumitra Pharmaceuticals & Chemicals Limited pursuant to a scheme of arrangement under Sections 391-394 of the Companies Act, 1956 |
184,299,640 |
18,429,964 |
| October 10, 1997 |
9,278,406 |
10 |
- |
Other than cash |
Allotment of 7,505,004 equity shares to shareholders of erstwhile Piramal Healthcare Limited and 1,773,402 equity shares to shareholders of erstwhile Boehringer Mannheim India Limited, pursuant to respective schemes of arrangement under Sections 391-394 of the Companies Act, 1956 |
277,083,700 |
27,708,370 |
| February 15, 2000 |
7,137,781 |
10 |
50 |
Cash |
Issued against the conversion of warrants held by shareholders of erstwhile Piramal Holdings Limited |
348,461,510 |
34,846,151 |
| March 29, 2000 |
6,900 |
10 |
50 |
Cash |
Issued against the conversion of warrants held by shareholders of our Company |
348,530,510 |
34,853,051 |
| August 9, 2000 |
150 |
10 |
50 |
Cash |
Issued to G. Ratnavali, one of then shareholder of our Company against the conversion of warrants held by him. |
348,532,010 |
34,853,201 |
| February 15, 2002 |
3,150,000 |
10 |
- |
Other than cash |
Allotment to shareholders of Rhone-Poulenc (India) Limited pursuant to a scheme of arrangement under Sections 391-394 of the Companies Act, 1956 |
380,032,010 |
38,003,201 |
| January 3, 2005 |
Subdivision of the equity shares from face value of ₹ 10 to face value of ₹ 2 each |
380,032,010 |
190,016,005 |
| September 25, 2005 |
18,997,128 |
2 |
175 |
Cash |
Equity Shares allotted pursuant to rights issue |
418,026,266 |
209,013,133 |
| July 16, 2007 |
11 |
2 |
175 |
Cash |
Equity Shares allotted out of the Equity Shares held in abeyance during the rights issue dated September 25, 2005 |
418,026,288 |
209,013,144 |
| March 29, 2011 |
-41,097,100 |
2 |
600 |
Cash |
Buy back of Equity Shares |
335,832,088 |
167,916,044 |
| June 15, 2011 |
-705,529 |
2 |
600 |
Cash |
Buy back of Equity Shares |
334,421,030 |
167,210,515 |
| December 30, 2011 |
5,352,585 |
2 |
2 |
Other than cash |
Allotment to shareholders of Piramal Life Sciences Limited pursuant to a scheme of arrangement under Sections 391-394 of the Companies Act, 1956 |
345,126,200 |
172,563,100 |
| November 24, 2017 |
225,000 |
2 |
- |
Other than cash |
Allotment pursuant to conversion of Compulsorily Convertible Debentures into Equity shares of the Company |
345,576,200 |
172,788,100 |
| March 8, 2018 |
7,485,574 |
2 |
2380 |
Cash |
Equity shares allotted pursuant to rights issue |
360,547,348 |
180,273,674 |
| May 7, 2018 |
121,200 |
2 |
- |
Other than cash |
Allotment pursuant to conversion of Compulsorily Convertible Debentures into Equity shares of the Company |
360,789,748 |
180,394,874 |
| May 15, 2018 |
197,640 |
2 |
- |
Other than cash |
Allotment pursuant to conversion of Compulsorily Convertible Debentures into Equity shares of the Company |
361,185,028 |
180,592,514 |
| July 5, 2018 |
5269 |
2 |
2380 |
Cash |
Allotment pursuant of shares out of CCD reservation portion under rights issue of the Company |
361,195,566 |
180,597,783 |
| August 31, 2018 |
200 |
2 |
- |
Other than cash |
Allotment pursuant to conversion of Compulsorily Convertible Debentures into Equity shares of the Company |
361,195,966 |
180,597,983 |
| September 7,2018 |
85,280 |
2 |
- |
Other than cash |
Allotment pursuant to conversion of Compulsorily Convertible Debentures into Equity shares of the Company |
361,366,526 |
180,683,263 |
| September 17,2018 |
3,715 |
2 |
2380 |
Cash |
Allotment pursuant of shares out of CCD reservation portion under rights issue of the Company |
361,373,956 |
180,686,978 |
| September 25,2018 |
302,000 |
2 |
- |
Other than cash |
Allotment pursuant to conversion of Compulsorily Convertible Debentures into Equity shares of the Company |
361,977,956 |
180,988,978 |
| October 5,2018 |
322,240 |
2 |
- |
Other than cash |
Allotment pursuant to conversion of Compulsorily Convertible Debentures into Equity shares of the Company |
362,622,436 |
181,311,218 |
| October 26,2018 |
1,373,240 |
2 |
- |
Other than cash |
Allotment pursuant to conversion of Compulsorily Convertible Debentures into Equity shares of the Company |
365,368,916 |
182,684,458 |
| November 16,2018 |
675,360 |
2 |
- |
Other than cash |
Allotment pursuant to conversion of Compulsorily Convertible Debentures into Equity shares of the Company |
366,719,636 |
183,359,818 |
| December 18,2018 |
52,440 |
2 |
- |
Other than cash |
Allotment pursuant to conversion of Compulsorily Convertible Debentures into Equity shares of the Company |
36,68,24,516 |
18,34,12,258 |
| January 16, 2019 |
186,000 |
2 |
- |
Other than cash |
Allotment pursuant to conversion of Compulsorily Convertible Debentures into Equity shares of the Company |
36,71,96,516 |
18,35,98,258 |
| February 4, 2019 |
441,920 |
2 |
- |
Other than cash |
Allotment pursuant to conversion of Compulsorily Convertible Debentures into Equity shares of the Company |
36,80,80,356 |
18,40,40,178 |
| March 14, 2019 |
404,480 |
2 |
- |
Other than cash |
Allotment pursuant to conversion of Compulsorily Convertible Debentures into Equity shares of the Company |
36,88,89,316 |
18,44,44,658 |
| March 19, 2019 |
2,314 |
2 |
2,380 |
Cash |
Equity Shares allotted out of the Right Shares held in abeyance under the rights issue of the Company |
36,88,93,944 |
18,44,46,972 |
| April 05, 2019 |
17,585 |
2 |
2,380 |
Cash |
Allotment pursuant of shares out of CCD reservation portion under rights issue of the Company |
36,89,29,114 |
18,44,64,557 |
| April 11, 2019 |
5,48,120 |
2 |
- |
Other than cash |
Allotment pursuant to conversion of Compulsorily Convertible Debentures into Equity shares of the Company |
37,00,25,354 |
18,50,12,677 |
| April 22, 2019 |
1,36,38,080 |
2 |
- |
Other than cash |
Allotment pursuant to conversion of Compulsorily Convertible Debentures into Equity shares of the Company |
39,73,01,514 |
19,86,50,757 |
| May 21, 2019 |
1,93,550 |
2 |
2,380 |
Cash |
Allotment pursuant of shares out of CCD reservation portion under rights issue of the Company |
39,76,88,614 |
19,88,44,307 |
| May 30, 2019 |
2,257 |
2 |
2,380 |
Cash |
Allotment pursuant of shares out of CCD reservation portion under rights issue of the Company |
39,76,93,128 |
19,88,44,307 |
